Light-to-Moderate Ethanol Feeding Augments AMPK-α Phosphorylation and Attenuates SREBP-1 Expression in the Liver of Rats

Abstract

Purpose: Fatty liver disease, a hepatic manifestation of metabolic syndrome, is one of the major causes of chronic liver diseases. Epidemiological studies suggest that regular light-to-moderate ethanol consumption lowers the risk of developing metabolic disorders including dislipidemia, insulin resistance, type 2 diabetes and fatty liver disease. However, the mechanism(s) of the protective effect of light-to-moderate ethanol consumption on the liver remains unknown. Methods: In the present study, we investigated the effects of light (6%, 0.94 g/kg/day) and moderate (12%, 1.88 g/kg/day) ethanol feeding in rats for 3 weeks on the circulating and hepatic biochemical profiles and on the hepatic protein expression and phosphorylation status of adenosine monophosphate-activated protein kinase-α (AMPK-α) and other down-stream targets of this enzyme including sterol regulatory element-binding protein-1 (SREBP-1), SREBP cleavage-activating protein (SCAP) and 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA reductase). Results: Despite no significant difference in food-intake among the groups, light ethanol treatment significantly increased the body weight compared to control rats. Serum glucose, insulin, total cholesterol, triglycerides, phospholipids and hepatic cholesterol and triglycerides were not significantly different among the groups. However, serum free fatty acids were significantly reduced with light ethanol treatment. Both light and moderate ethanol treatment significantly increased the hepatic levels of phosphorylated AMPK-α protein and this was associated with significant reduction of SREBP-1 protein expression, suggesting an enhanced fatty acid oxidation. In addition, light ethanol treatment significantly decreased the SCAP protein expression in the liver. However, liver HMG-CoA protein expression was not significantly different with ethanol consumption. Conclusion: Chronic light-to-moderate ethanol consumption increased AMPK activation which was associated with decreased expression of SREBP-1 and SCAP in the liver. Thus, our studies provide mechanistic evidence for the earlier epidemiological studies that indicate light-to-moderate ethanol intake lowers the risk of development of fatty liver disease and other metabolic disorders. Our studies demonstrate that the protective effects of light-to-moderate ethanol arise at least in part by increased phosphorylation of AMPK-α and decreased SREBP-1 expression in the liver. Further studies are warranted to determine the effects of light-to-moderate ethanol on intracellular up-stream and down-stream targets of AMPK and also on the implications of light-to-moderate ethanol in protecting non-alcoholic fatty liver disease. This article is open to POST-PUBLICATION REVIEW. Registered readers (see “For Readers”) may comment by clicking on ABSTRACT on the issue’s contents page.

Alcoholic Steatosis in Different Strains of Rat: A Comparative Study

“…AMPK plays a key role in regulating the effects of ethanol on hepatic SREBP-1 activation, fatty acid metabolism, and the development of alcoholic fatty liver [ 32 ]. Increased expression of AMPK and decreased expression of SREBP-1 as observed are in agreement with the literature linking AMPK and SREBP-1 [ 38 , 39 , 40 , 41 ]. SREBP-2 regulates the genes of cholesterol biosynthesis and metabolism in hepatocytes [ 26 , 42 ].…”

Hepatoprotective effects of sea cucumber ether-phospholipids against alcohol-induced lipid metabolic dysregulation and oxidative stress in mice

“…38 These contradictory results may be due to different pathological degrees of ALD. 39 The present results showed that chronic alcohol consumption had no obvious effect on hepatic fatty acid oxidation, but it significantly increased TG synthesis genes (Dgat1). PlsEtn, PlsCho and NAC treatment efficiently inhibited fatty acid uptake and TG synthesis.…”

CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis

“…With respect to alcohol's effect on hepatic DNL, there is no consensus in the literature regarding this important contributor to hepatic TG levels. While it has been reported by You et al that alcohol increases SREBP1c expression with resultant effects on hepatic fatty acid synthesis ( 26,27 ), others have recently reported that alcohol consumption decreases SREBP1c expression ( 28 ). Our results are in agreement with Tijburg et al and Venkatesan et al, who conducted Although G6pc (glucose synthesis) expression was not signifi cantly different in any group, Pepck expression was signifi cantly higher in Cd36 Ϫ / Ϫ versus WT mice, suggesting increased gluconeogenesis in these animals.…”